Botanical species · safety record

Echinopsis pachanoi

The EFSA Compendium of Botanicals holds 8 constituent measurements for Echinopsis pachanoi. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Echinopsis pachanoi (Britton & Rose) Friedrich & G.D.Rowley

8Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Also recorded as

Trichocereus pachanoi Britton & Rose

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Mescaline	Aerial part of plants	Solvent extraction	≥ 0.54 Percent	GC-MS	Resolve DOI
Mescaline	Live plants	Solvent extraction	≤ 23.75 Gram/kilogram	Chromatographic tests	Resolve DOI
Mescaline	Live plants	Solvent extraction	≥ 1.09 Gram/kilogram	Chromatographic tests	Resolve DOI
Mescaline	Aerial part of plants	Solvent extraction	≤ 4.7 Percent	GC-MS	Resolve DOI
Pentacyclic triterpene glycosides	Live plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Lophophine	Unspecified	Solvent extraction	—	GC-MS	No resolvable identifier
Mescaline	Unspecified	—	—	Gaschromatography (GC)	No resolvable identifier
Mescaline	Unspecified	Solvent extraction	—	GC-MS	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Ogunbodede, Olabode., McCombs, Douglas., Trout, Keeper., Daley, Paul., Terry, Martin. New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) (San Pedro) and their relevance to shamanic practice. JOURNAL OF ETHNOPHARMACOLOGY, 2010, vol. 131, no. 2, p. 356-362. DOI
HELMLIN, HJ., BRENNEISEN, R. DETERMINATION OF PSYCHOTROPIC PHENYLALKYLAMINE DERIVATIVES IN BIOLOGICAL MATRICES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH PHOTODIODE-ARRAY DETECTION . Journal of chromatography, 1992, vol. 593, no. 1-2, p. 87-94. DOI
Bruhn, Jan G., El-Seedi, Hesharn R., Stephanson, Nikolai., Beck, Olof., Shulgin, Alexander T. Ecstasy analogues found in cacti. Journal of psychoactive drugs, 2008, vol. 40, no. 2, p. 219-222.
Agurell, Stig., Lundstrom, Jan. Apparent intermediates in the biosynthesis of mescaline and related tetrahydroisoquinolines. Chemical communications (london), 1968, vol. (24), p. 1638-9.
Kinoshita, K., Takizawa, T., Koyama, K., Takahashi, K., Kondo, N., Yuasa, H., Kawai, KI. New triterpenes from Trichocereus pachanoi. Journal of natural products, 1995, vol. 58, no. 11, p. 1739-1744. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature